Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the medical devices industry, is currently capturing the attention of savvy investors. With a notable potential upside of 31.80%, as highlighted by analysts’ average target price, the stock presents an intriguing opportunity. Let’s delve into the financial landscape and performance metrics that define this healthcare sector entity.

**Company Snapshot**

Headquartered in Princeton, New Jersey, Integra LifeSciences specializes in manufacturing and selling an array of surgical instruments and devices. Its offerings cater to neurosurgery, neurocritical care, and otolaryngology through its two primary segments: Codman Specialty Surgical and Tissue…